Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.

Literature DB >> 2712543

In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.

J Segreti¹, H A Kessler, K S Kapell, G M Trenholme.

Abstract

The in vitro activity of temafloxacin (A-62254), a new quinolone antibiotic, against 13 strains of Chlamydia trachomatis was determined and compared with those of doxycycline, norfloxacin, ciprofloxacin, and difloxacin. Temafloxacin and difloxacin were the most active quinolones tested, with bactericidal activity comparable to that of doxycycline.

Entities: Chemical Species

Mesh：

Substances：

Year: 1989 PMID： 2712543 PMCID： PMC171434 DOI： 10.1128/AAC.33.1.118

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

10 in total

1. In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.

Authors: W R Bowie; C E Shaw; D G Chan; J Boyd; W A Black
Journal: Antimicrob Agents Chemother Date: 1986-10 Impact factor: 5.191

2. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.

Authors: K H Tjiam; J H Wagenvoort; B van Klingeren; P Piot; E Stolz; M F Michel
Journal: Eur J Clin Microbiol Date: 1986-10 Impact factor: 3.267

3. Ultrastructural analysis of the effect of trimethoprim and sulphamethoxazole on the development of Chlamydia trachomatis in cell culture.

Authors: M R Hammerschlag; J C Vuletin
Journal: J Antimicrob Chemother Date: 1985-02 Impact factor: 5.790

4. In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.

Authors: H Maeda; A Fujii; K Nakata; S Arakawa; S Kamidono
Journal: Antimicrob Agents Chemother Date: 1988-07 Impact factor: 5.191

5. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.

Authors: L D Liebowitz; J Saunders; G Fehler; R C Ballard; H J Koornhof
Journal: Antimicrob Agents Chemother Date: 1986-12 Impact factor: 5.191

Review 6. Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis.

Authors: J D Oriel
Journal: J Antimicrob Chemother Date: 1986-11 Impact factor: 5.790

7. In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.

Authors: F W Heessen; H L Muytjens
Journal: Antimicrob Agents Chemother Date: 1984-01 Impact factor: 5.191

1 in total

1. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.

Authors: J Segreti; D J Hirsch; A A Harris; K S Kapell; H Orbach; H A Kessler
Journal: Antimicrob Agents Chemother Date: 1990-06 Impact factor: 5.191